Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo

Medicine & Life Sciences

• Anthrax 26%
• Anthrax Vaccines 15%
• Antibodies 10%
• Antibody Formation 70%
• Antibody-Producing Cells 25%
• Antigens 12%
• B-Lymphocytes 60%
• Communicable Diseases 8%
• Cytokine Receptors 11%
• Dendritic Cells 8%
• Differentiation Antigens 10%
• Histocompatibility Antigens Class II 10%
• Human Influenza 18%
• Immunity 8%
• Immunization 8%
• In Vitro Techniques 34%
• Influenza Vaccines 11%
• Knockout Mice 9%
• Ligands 6%
• Plasma Cells 19%
• Poly I-C 100%
• Proteins 28%
• Serum 4%
• T-Lymphocytes 6%
• Toll-Like Receptors 32%
• Vaccines 58%